{"disease":{"id":"embryonal-carcinoma","name":"embryonal carcinoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03382158","title":"International PPB/DICER1 Registry","phase":"","overall_status":"RECRUITING","enrollment_count":3400,"lead_sponsor_name":"Children's Hospitals and Clinics of Minnesota","has_results":false},{"nct_id":"NCT03067181","title":"Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":1780,"lead_sponsor_name":"Children's Oncology Group","has_results":false},{"nct_id":"NCT03959800","title":"Molecular Basis of Pediatric Liver Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":1600,"lead_sponsor_name":"University of Pittsburgh","has_results":false},{"nct_id":"NCT05564026","title":"Molecular Epidemiology of Pediatric Germ Cell Tumors","phase":"","overall_status":"RECRUITING","enrollment_count":1151,"lead_sponsor_name":"Children's Oncology Group","has_results":false},{"nct_id":"NCT01434355","title":"DNA Analysis in Samples From Younger Patients With Germ Cell Tumors and Their Parents or Siblings","phase":"","overall_status":"COMPLETED","enrollment_count":932,"lead_sponsor_name":"Children's Oncology Group","has_results":false},{"nct_id":"NCT00053352","title":"Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":302,"lead_sponsor_name":"Children's Oncology Group","has_results":true},{"nct_id":"NCT04684368","title":"A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":160,"lead_sponsor_name":"Children's Oncology Group","has_results":false},{"nct_id":"NCT07148050","title":"Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":21,"lead_sponsor_name":"Seattle Children's Hospital","has_results":false},{"nct_id":"NCT00467051","title":"Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Children's Oncology Group","has_results":true},{"nct_id":"NCT02689219","title":"Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":18,"lead_sponsor_name":"Nabil Adra","has_results":true}],"total":10},"guidelines":[],"source":"Drug Landscape verified database"}